Bryan Ball - Apr 23, 2024 Form 3 Insider Report for Aadi Bioscience, Inc. (AADI)

Role: Exhibit 24 - Power of Attorney Chief Technical Operations Officer and SVP, Manufacturing Operations
Signature: /s/ Stephen Rodin, as Attorney-in-Fact
Stock symbol: AADI
Transactions as of: Apr 23, 2024
Transactions value $: $0
Form type: 3
Date filed: 4/26/2024, 04:50 PM
Previous filing: Jul 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AADI	Common Stock						100K	Apr 23, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AADI	Stock option (right to buy)							Apr 23, 2024	Common Stock	148K	$13.97	Direct	F1
holding	AADI	Stock option (right to buy)							Apr 23, 2024	Common Stock	50K	$10.93	Direct	F2
holding	AADI	Stock option (right to buy)							Apr 23, 2024	Common Stock	65.8K	$1.92	Direct
holding	AADI	Stock option (right to buy)							Apr 23, 2024	Common Stock	40K	$1.92	Direct	F3
holding	AADI	Restricted Stock Units							Apr 23, 2024	Common Stock	20K		Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option vested on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean August 15, 2022.
F2	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option vested on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2023.
F3	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2024.
F4	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.
F5	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.

Remarks:

Exhibit 24 - Power of Attorney Chief Technical Operations Officer and SVP, Manufacturing Operations